News | Atrial Fibrillation | November 10, 2023

Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023

Smidt Heart Institute experts to present study results on AFib, sudden cardiac arrest 

Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai.

Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai. 


November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai will unveil research and clinical insights during the American Heart Association (AHA) Scientific Sessions Nov. 11-13 in Philadelphia. 

Joanna Chikwe, MD, chair of the Department of Cardiac Surgery and the Irina and George Schaeffer Distinguished Chair in Cardiac Surgery, will lead sessions on valvular heart disease including the Paul Dudley White International Lecture. Chikwe serves as vice chair of the AHA Scientific Sessions. 

Sumeet Chugh, MD, director of the Center for Cardiac Arrest Prevention and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research, will moderate an AHA featured science session and share new research on prevention of sudden cardiac death.  

Christine Albert, MD, MPH, chair of the Department of Cardiology and the Lee and Harold Kapelovitz Distinguished Chair in Cardiology, will moderate a late-breaking session on shocking decisions in atrial fibrillation (AFib) care. Albert has led pivotal studies that have deepened the medical community’s understanding of the complex disease.  

For more information: www.cedars-sinai.org 

 

Find more AHA23 conference coverage here 


Related Content

News | Atrial Fibrillation

Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...

Home February 09, 2026
Home
News | Atrial Fibrillation

Feb. 9, 2026 — Atraverse Medical presented new clinical and preclinical data at AF Symposium 2026 in Boston, further ...

Home February 09, 2026
Home
News | Atrial Fibrillation

Dec. 19, 2025 — Johnson & Johnson MedTech has announced its sponsorship of a new data collection platform developed by ...

Home December 19, 2025
Home
Feature | Atrial Fibrillation | Jeffrey Olgin, M.D.

Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...

Home September 12, 2025
Home
News | Atrial Fibrillation

Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...

Home September 08, 2025
Home
News | Atrial Fibrillation

Sept. 8, 2025 — AMO Pharma Ltd., a clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders ...

Home September 08, 2025
Home
Feature | Atrial Fibrillation

Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 ...

Home September 04, 2025
Home
News | Atrial Fibrillation

June 13, 2025 — An international study has shown that targeted online education on atrial fibrillation (AF) for health ...

Home June 16, 2025
Home
News | Atrial Fibrillation

May 21, 2025 — Corify Care recently announced it has entered into a know-how agreement with Mayo Clinic. Corify Care is ...

Home May 22, 2025
Home
News | Atrial Fibrillation

April 25, 2025 – Medtronic plc, a global leader in healthcare technology, recently received U.S. Food and Drug ...

Home April 29, 2025
Home
Subscribe Now